Gede P. Supadmanaba
Denpasar, BA, Indonesia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
The Emerging Role and Clinical Impact of Vitamin D Supplementation in Breast Cancer Patients Undergoing Chemotherapy: A Systematic Review.
Journal: Acta medica (Hradec Kralove)
Published: August 11, 2026
Early diagnostic accuracy of immature platelet fraction for sepsis: a systematic review and meta-analysis.
Journal: Hematology, transfusion and cell therapy
Published: November 22, 2025
A Network Meta-Analysis Comparing the Efficacy of Lenvatinib, Atezolizumab plus Bevacizumab, and Sorafenib in the Treatment of Unresectable Hepatocellular Carcinoma.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: September 07, 2025
Relationship Between XRCC1 Arg399gln Polymorphism and Risk of Luminal Subtype Breast Cancer in Bali, Indonesia.
Journal: Acta medica (Hradec Kralove)
Published: June 16, 2025
Prognostic Significance of Up-to-Seven Criteria Versus Milan Criteria for Hepatocellular Carcinoma Patients Undergoing Resection or Locoregional Therapy: A Systematic Review and Meta-Analysis.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: March 30, 2025
The Relationship Between Comprehensive OSCE Scores and GPA on the Readiness of Undergraduate Medical Students to Undergo Clinical Rotations.
Journal: The Malaysian journal of medical sciences : MJMS
Published: January 17, 2025
Plasma level of cancer stem cell marker aldehyde dehydrogenase 1 (ALDH1) is higher in locally advance cervical cancer.
Journal: Taiwanese journal of obstetrics & gynecology
Published: January 15, 2025
Efficacy and Safety of Lenvatinib versus Atezolizumab Plus Bevacizumab in the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: January 02, 2025
Efficacy of Lenvatinib Versus Sorafenib in the Treatment of Unresectable Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: January 02, 2025
Assessment of SF3B1 Expression as a Prognostic Marker for Neoadjuvant Chemotherapy Response in Stage III Triple-Negative Breast Cancer.
Journal: Reports of biochemistry & molecular biology
Published: December 28, 2024
Correlation of CD44 Protein Expression with Larger Tumor Size and Advanced Stage of Breast Cancer Patients.
Journal: Asian Pacific journal of cancer prevention : APJCP
Published: May 02, 2024
Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target.
Journal: International journal of biological sciences
Published: November 28, 2023
Last Updated: 09/26/2026